Verrica Pharmaceuticals Announces Presentation at the RBC Capital Markets Global Healthcare Conference

Rhea-AI Summary

Verrica Pharmaceuticals Inc. announced that Ted White, Verrica President & Chief Executive Officer, will present at the RBC Capital Markets Global Healthcare Conference on May 17, 2023. The event will be held at the InterContinental New York Barclay Hotel and participants can access a live webcast through the provided link. The webcast replay will be available within 24 hours after the event.

WEST CHESTER, Pa., May 10, 2023 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that Ted White, Verrica President & Chief Executive Officer, will present at the upcoming RBC Capital Markets Global Healthcare Conference, which is being held at the InterContinental New York Barclay Hotel from May 16-17, 2023.

Event details:

Date: Wednesday, May 17, 2023

Time: 8:30 am ET

Location: InterContinental New York Barclay Hotel

Participants may access a live webcast of the event through the following link: http://www.veracast.com/webcasts/rbc/healthcare2023/YTj1aT.cfm

The webcast can also be accessed in the Investors/Presentations & Events section of the Verrica website at www.verrica.com. The webcast replay will be available within 24 hours after conclusion of live event, and the webcast replay expires on August 15, 2023.

About Verrica Pharmaceuticals Inc.
Verrica is a dermatology therapeutics company developing medications for skin diseases requiring medical interventions. Verrica’s late-stage product candidate, VP-102, is in development to treat molluscum, common warts and external genital warts, three of the largest unmet needs in medical dermatology. Verrica is also developing VP-103, its second cantharidin-based product candidate, for the treatment of plantar warts. The Company has also entered into a worldwide license agreement with Lytix Biopharma AS to develop and commercialize VP- 315 (formerly LTX-315 and VP-LTX-315) for dermatologic oncology conditions. For more information, visit www.verrica.com.

FOR MORE INFORMATION, PLEASE CONTACT:
Investors:

Terry Kohler 
Chief Financial Officer
info@verrica.com

Kevin Gardner
LifeSci Advisors
kgardner@lifesciadvisors.com

Chris Calabrese
LifeSci Advisors
ccalabrese@lifesciadvisors.com

FAQ

What is the name of the company mentioned in the press release?

The company mentioned in the press release is Verrica Pharmaceuticals Inc.

Who will be presenting at the RBC Capital Markets Global Healthcare Conference?

Ted White, Verrica President & Chief Executive Officer, will be presenting at the conference.

Where will the conference be held?

The conference will be held at the InterContinental New York Barclay Hotel.

How can participants access the live webcast of the event?

Participants can access the live webcast through the provided link: http://www.veracast.com/webcasts/rbc/healthcare2023/YTj1aT.cfm

When will the webcast replay be available?

The webcast replay will be available within 24 hours after the conclusion of the live event.

When does the webcast replay expire?

The webcast replay expires on August 15, 2023.